Zobrazeno 1 - 10
of 195
pro vyhledávání: '"B, Vidriales"'
Autor:
Sergio Matarraz, Pilar Leoz, Ana Yeguas-Bermejo, Vincent van der Velden, Anne E. Bras, Jose I. Sánchez Gallego, Quentin Lecrevisse, Rosa Ayala-Bueno, Cristina Teodosio, Ignacio Criado, María González-González, Juan Flores-Montero, Alejandro Avendaño, María B. Vidriales, María C. Chillón, Teresa González, Ramón García-Sanz, María I. Prieto Conde, Neus Villamor, Laura Magnano, Enrique Colado, Paula Fernández, Edwin Sonneveld, Jan Philippé, Michaela Reiterová, Juan C. Caballero Berrocal, Francisco J. Diaz-Gálvez, Fernando Ramos, Julio Dávila Valls, Raquel Manjón Sánchez, Jackeline Solano Tovar, Xavier Calvo, Luis García Alonso, Leonor Arenillas, Sara Alonso, Ariana Fonseca, Covadonga Quirós Caso, Jacques J. M. van Dongen, Alberto Orfao
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-5 (2023)
Externí odkaz:
https://doaj.org/article/766fb597b8d64b8abd7b459cf4d44310
Autor:
David Martínez-Cuadrón, Juan E. Megías-Vericat, Cristina Gil, Teresa Bernal, Mar Tormo, Pilar Martínez-Sánchez, Carlos Rodríguez-Medina, Josefina Serrano, Pilar Herrera, José A. Pérez Simón, María J. Sayas, Juan Bergua, Esperanza Lavilla-Rubira, Maria Luz Amigo, Celina Benavente, Jose L. López Lorenzo, Manuel M. Pérez-Encinas, María B. Vidriales, Mercedes Colorado, Beatriz de Rueda, Raimundo García-Boyero, Sandra Marini, Julio García-Suárez, María López-Pavía, Maria I. Gómez-Roncero, Víctor Noriega, Aurelio López, Jorge Labrador, Ana Cabello, Claudia Sossa, Lorenzo Algarra, Mariana Stevenazzi, Antonio Solana-Altabella, Blanca Boluda, Pau Montesinos
Publikováno v:
Haematologica, Vol 109, Iss 1 (2023)
Treatment options for patients with secondary acute myeloid leukemia (sAML) and AML with myeloid-related changes (AMLMRC) aged 60 to 75 years are scarce and unsuitable. A pivotal trial showed that CPX-351 improved complete remission with/without inco
Externí odkaz:
https://doaj.org/article/f978279b26d241eca282876eec8ca76b
Autor:
Tamara Castaño-Bonilla, Juan M. Alonso-Dominguez, Eva Barragán, Rebeca Rodríguez-Veiga, Claudia Sargas, Cristina Gil, Carmen Chillón, María B. Vidriales, Raimundo García, Joaquín Martínez-López, Rosa Ayala, María J. Larrayoz, Eduardo Anguita, Rebeca Cuello, Alberto Cantalapiedra, Estrella Carrillo, Elena Soria-Saldise, Jorge Labrador, Isabel Recio, Lorenzo Algarra, Carlos Rodríguez-Medina, Cristina Bilbao-Syeiro, Juan A. López-López, Josefina Serrano, Erik De Cabo, María J. Sayas, María T. Olave, Joaquín Sánchez-García, Mamen Mateos, Carlos Blas, Jose L. López-Lorenzo, Daniel Lainez-Gonzalez, Juana Serrano, David Martínez-Cuadrón, Miguel A. Sanz, Pau Montesinos
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract FLT3-ITD mutations are detected in approximately 25% of newly diagnosed adult acute myeloid leukemia (AML) patients and confer an adverse prognosis. The FLT3-ITD allelic ratio has clear prognostic value. Nevertheless, there are numerous manu
Externí odkaz:
https://doaj.org/article/fdbb40702f114bf78acc458a1b88a71c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alejandro Diego‐Nieto, Maria B. Vidriales, Norberto Alonso‐Orcajo, Jose C. Moreno‐Samos, Francisco Martin‐Herrero, Raul Carbonell, Belen Cid, Ignacio Cruz‐Gonzalez, Javier C. Martin‐Moreiras, Carlos Cuellas, Cristina Pascual, Maria Lopez‐Benito, Pedro L. Sanchez, Felipe Fernandez‐Vazquez, Armando Perez de Prado
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 19 (2018)
Background Ticagrelor use during acute coronary syndromes demonstrated a decrease in all‐cause mortality in the PLATO (Platelet Inhibition and Patient Outcomes) trial. This effect has been attributed to a non–platelet‐derived improvement in end
Externí odkaz:
https://doaj.org/article/f2b404cda6714a4d97a349f6ccf03977
Autor:
David, Martínez-Cuadrón, Josefina, Serrano, José, Mariz, Cristina, Gil, Mar, Tormo, Pilar, Martínez-Sánchez, Eduardo, Rodríguez-Arbolí, Raimundo, García-Boyero, Carlos, Rodríguez-Medina, Carmen, Martínez-Chamorro, Marta, Polo, Juan, Bergua, Eliana, Aguiar, María L, Amigo, Pilar, Herrera, Juan M, Alonso-Domínguez, Teresa, Bernal, Ana, Espadana, María J, Sayas, Lorenzo, Algarra, María B, Vidriales, Graça, Vasconcelos, Susana, Vives, Manuel M, Pérez-Encinas, Aurelio, López, Víctor, Noriega, María, García-Fortes, María C, Chillón, Juan I, Rodríguez-Gutiérrez, María J, Calasanz, Jorge, Labrador, Juan A, López, Blanca, Boluda, Rebeca, Rodríguez-Veiga, Joaquín, Martínez-López, Eva, Barragán, Miguel A, Sanz, Pau, Montesinos, On Behalf Of The Pethema Group
Publikováno v:
Cancers. 14(11)
This retrospective study investigated outcomes of 404 patients with relapsed/refractory (R/R) FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) acute myeloid leukemia (AML) enrolled in the PETHEMA registry, pre-approval of tyrosine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::82e014c965f315b1408bfc3617b5abe3
https://pubmed.ncbi.nlm.nih.gov/35681796
https://pubmed.ncbi.nlm.nih.gov/35681796
Autor:
Francisco-Javier Peñalver, M. Guinea, B. Vidriales, Jesús María Hernández-Rivas, C. Grande, Alejandro Martín, R. Fernández, A. Batlle, María Teresa García-Álvarez, Juan-Manuel Sancho, MJ Peñarrubia, A. Orfao, J.J. Pérez, Susana Barrena, Miguel Alcoceba, Mónica Baile
Publikováno v:
Hematological Oncology. 37:362-364
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a271a95acdcfceec51e848f61f5251f
https://doi.org/10.1002/hon.26_2631
https://doi.org/10.1002/hon.26_2631
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Francisco Martín-Herrero, Pedro L. Sánchez, Norberto Alonso-Orcajo, Alejandro Diego-Nieto, Cristina Pascual, María López-Benito, Jose Carlos Moreno-Samos, Javier Martín-Moreiras, Ignacio Cruz-González, Maria B. Vidriales, Felipe Fernández-Vázquez, Carlos Cuellas, Armando Pérez de Prado, Belen Cid, Raul Carbonell
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Ticagrelor use during acute coronary syndromes demonstrated a decrease in all‐cause mortality in the PLATO (Platelet Inhibition and Patient Outcomes) trial. This effect has been attributed to a non–platelet‐derived improvement in end
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f57fa2b6b202ea1456f93afcebbc9474
https://doi.org/10.1161/jaha.118.009444
https://doi.org/10.1161/jaha.118.009444
Autor:
Roberia Pontes, Luis Palomera, M.V. Mateos, Brian G.M. Durie, Marcos González, Juan Flores-Montero, Juan F. Blanco, M B Vidriales, Juan José Garcés, Juana Merino, Jesús F. San-Miguel, Ramón García-Sanz, J Hernández-Martín, O García-Sánchez, Alba Corral-Mateos, Bruno Paiva, N. Puig, J J M van Dongen, Paula Rodriguez-Otero, Martin Perez-Andres, Aránzazu García-Mateo, Felipe Prosper, Elena Blanco, Luzalba Sanoja-Flores, Pamela Millacoy, Rafael Ríos-Tamayo, Alberto Orfao, Alfonso Romero, María Díez-Campelo, Leire Burgos
Publikováno v:
Blood Cancer Journal, 8
Digital.CSIC: Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Digital.CSIC. Repositorio Institucional del CSIC
Blood Cancer Journal
Blood Cancer Journal, Vol 8, Iss 12, Pp 1-11 (2018)
Digital.CSIC: Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Digital.CSIC. Repositorio Institucional del CSIC
Blood Cancer Journal
Blood Cancer Journal, Vol 8, Iss 12, Pp 1-11 (2018)
© The Author(s) 2018.
Here, we investigated for the first time the frequency and number of circulating tumor plasma cells (CTPC) in peripheral blood (PB) of newly diagnosed patients with localized and systemic plasma cell neoplasms (PCN) using
Here, we investigated for the first time the frequency and number of circulating tumor plasma cells (CTPC) in peripheral blood (PB) of newly diagnosed patients with localized and systemic plasma cell neoplasms (PCN) using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f38f01a560f0053584c74c04e187e0c
https://hdl.handle.net/10171/56820
https://hdl.handle.net/10171/56820
